feed,title,long_url,short_url
InsiderMonkey,Morgan Stanley Assumes Coverage of Axsome Therapeutics (AXSM) with an Overweight Rating,https://insidermonkey.com/blog/--1563518,
InsiderMonkey,"Morgan Stanley Raises PT on Apellis Pharmaceuticals (APLS) to $26, Keeps a Hold Rating",https://insidermonkey.com/blog/--1563519,
InsiderMonkey,Alvotech (ALVO) Announces a Commercialization Agreement With Advanz Pharma,https://insidermonkey.com/blog/--1563520,
InsiderMonkey,William Blair Initiates Coverage of Harrow (HROW) With an Outperform Rating,https://insidermonkey.com/blog/--1563521,
InsiderMonkey,Corcept Therapeutics (CORT) Announces Pivotal Data from Phase 3 ROSELLA Trial,https://insidermonkey.com/blog/--1563522,
InsiderMonkey,Leerink Partners Reiterates a Bullish Stance on Travere Therapeutics (TVTX),https://insidermonkey.com/blog/--1563523,
InsiderMonkey,Piper Sandler Maintains a Buy Rating on Cytokinetics (CYTK) With a $107 PT,https://insidermonkey.com/blog/--1563524,
InsiderMonkey,H.C. Wainwright Reiterates a Buy Rating on Beam Therapeutics (BEAM) With an $80 PT,https://insidermonkey.com/blog/--1563525,
InsiderMonkey,H.C. Wainwright Maintains a Buy on Legend Biotech (LEGN) With a $75 Price Target,https://insidermonkey.com/blog/--1563526,
InsiderMonkey,"Morgan Stanley Lifts PT on CG Oncology (CGON) to $56, Keeps an Overweight Rating",https://insidermonkey.com/blog/--1563527,
InsiderMonkey,Citizens JMP Reiterates a Buy Rating on Dynavax Technologies (DVAX) With a Price Target of $31,https://insidermonkey.com/blog/--1563528,
InsiderMonkey,"Amicus Therapeutics (FOLD) Announces Approval for Pombiliti + Opfolda by Japanâ€™s Ministry of Health, Labour and Welfare (MHLW)",https://insidermonkey.com/blog/--1563529,
InsiderMonkey,LifeSci Capital Maintains a Buy on Immunovant (IMVT) With a $50 PT,https://insidermonkey.com/blog/--1563530,
InsiderMonkey,"POSCO Holdings to Build US Lithium Plant, Supports EV Supply Chain",https://insidermonkey.com/blog/--1563602,
InsiderMonkey,Summit Therapeutics Reportedly Makes $15B AstraZeneca Licensing Talks for Lung Cancer Drug,https://insidermonkey.com/blog/--1563604,
InsiderMonkey,Apogee Therapeutics Shares Positive Interim Phase 1b Results for APG808 in Asthma,https://insidermonkey.com/blog/--1563605,
InsiderMonkey,Globalstar Begins Major C-3 Satellite System Ground Expansion with First Antenna Installation in Texas,https://insidermonkey.com/blog/--1563606,
InsiderMonkey,Citius Pharmaceuticals Prepares for Q2 2025 Commercial Launch of FDA-Approved Cancer Drug LYMPHIR,https://insidermonkey.com/blog/--1563607,
InsiderMonkey,UroGen Pharma Receives FDA Approval for ZUSDURI for Recurrent Bladder Cancer,https://insidermonkey.com/blog/--1563608,
InsiderMonkey,"Prime Medicine Focuses on Genetic Liver Diseases, Partnered Programs After Positive CGD Data",https://insidermonkey.com/blog/--1563609,
